MEDANTA vs LALPATHLAB: Stock Comparison
Head-to-head financial and trading comparison between Global Health Limited (MEDANTA) and Dr. Lal Path Labs Ltd. (LALPATHLAB) in the Hospitals & Diagnostics sector.
MEDANTA
NSE: MEDANTALALPATHLAB
NSE: LALPATHLABKey Metrics Comparison Table
| Metric | MEDANTA | LALPATHLAB | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,357.30 | ₹2,005.10 | — |
| 1-Year Price Return | +27.31% | +42.74% | LALPATHLAB (15.43% higher) |
| 52-Week High | ₹1,508.90 | ₹2,005.10 | — |
| 52-Week Low | ₹1,061.45 | ₹1,367.20 | — |
| 30-Day Annualized Volatility | 36.04% | 16.31% | LALPATHLAB (Steadier) |
| 30-Day Average Daily Volume | 285,547 | 298,732 | LALPATHLAB (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MEDANTA and LALPATHLAB, which stock gave better returns over the last year?
LALPATHLAB has outperformed MEDANTA over the past 12 months with a gain of 42.74% compared to 27.31%.
Which stock is less volatile: MEDANTA or LALPATHLAB?
LALPATHLAB demonstrated lower price volatility (16.31% annualized) compared to MEDANTA (36.04%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MEDANTA vs LALPATHLAB?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MEDANTA and LALPATHLAB direct sector competitors?
Yes, both companies operate within the Hospitals & Diagnostics sector in India and are actively tracked as sector peers by institutional and retail market participants.